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Abstract
Background: To better understand potential transmission risks from contact with the body fluids of children, we
monitored the presence and amount of CMV shedding over time in healthy CMV-seropositive children.
Methods: Through screening we identified 36 children from the Atlanta, Georgia area who were CMV-seropositive,
including 23 who were shedding CMV at the time of screening. Each child received 12 weekly in-home visits at
which field workers collected saliva and urine. During the final two weeks, parents also collected saliva and urine
daily.
Results: Prevalence of shedding was highly correlated with initial shedding status: children shedding at the
screening visit had CMV DNA in 84% of follow-up saliva specimens (455/543) and 28% of follow-up urine specimens
(151/539); those not shedding at the screening visit had CMV DNA in 16% of follow-up saliva specimens (47/303)
and 5% of follow-up urine specimens (16/305). Among positive specimens we found median viral loads of 82,900
copies/mL in saliva and 34,730 copies/mL in urine (P = 0.01), while the viral load for the 75th percentile was nearly
1.5 million copies/mL for saliva compared to 86,800 copies/mL for urine. Younger age was significantly associated
with higher viral loads, especially for saliva (P < 0.001). Shedding prevalence and viral loads were relatively stable
over time. All children who were shedding at the screening visit were still shedding at least some days during
weeks 11 and 12, and median and mean viral loads did not change substantially over time.
Conclusions: Healthy CMV-seropositive children can shed CMV for months at high, relatively stable levels. These
data suggest that behavioral prevention messages need to address transmission via both saliva and urine, but also
need to be informed by the potentially higher risks posed by saliva and by exposures to younger children.
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Background
Congenital cytomegalovirus (CMV) infection is an im-
portant cause of birth defects and developmental disabil-
ities, including hearing loss, vision loss, and intellectual
disability [1,2]. CMV infection can be transmitted to the
fetus during pregnancy when the mother has a primary
(i.e., first) infection, a re-infection with a new strain, or a
viral reactivation [3]. Preventing primary or re-infection
through behavioral changes [4-6] is of great importance,
especially since there is no licensed vaccine [7,8] or
established treatment for pregnant women [9-11].
In order to more successfully prevent CMV transmis-
sion to pregnant women, it is important to improve our
understanding of transmission modes. CMV can be
transmitted in several ways, all of which require close
contact with infected body fluids. Although transmission
through intimate contact (e.g., kissing, sex) with an
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infected adult is important [12,13], especially among
those with multiple sexual partners, seroconversion stud-
ies suggest that, for many women, exposure to young chil-
dren may be even more important [14].
To better understand the potential risk associated with
exposure to saliva and urine of healthy CMV-seropositive
children, we carried out a repeated measures study of
CMV shedding (i.e., presence of viral DNA in body fluids).
In contrast to most previous studies, we measured viral
loads, tested both saliva and urine, and assessed changes
over time, including at weekly and daily intervals.
Through this study we hoped to inform and refine our
knowledge about transmission modes in order to bet-




We identified participants for longitudinal follow-up from
a convenience sample of children without chronic medical
conditions aged 0–47 months in the Atlanta, Georgia
metropolitan area (Stowell et al., companion paper).
None of the children had a diagnosis of congenital
CMV infection. To be eligible for follow-up, the chil-
dren first had to test positive for anti-CMV IgG—50 of
161 children met this criterion (Stowell et al., compan-
ion paper). Of these children, we enrolled 23 of 25
(92%) who also tested positive for CMV DNA in saliva
and/or urine. In addition, we enrolled some seroposi-
tive non-shedders (N = 13) so that we could assess
spontaneous initiation of shedding. We obtained approval
for the study from the Institutional Review Board (IRB) at
the U.S. Centers for Disease Control and Prevention
(CDC), and we obtained informed consent for the chil-
dren from their mothers.
Specimen collection and storage
After the initial screening visit, we carried out 12 in-home
visits for each participant, conducted at weekly intervals.
At each visit, field workers collected saliva using a sterile
oral swab. Swabs remained in the children’s mouths for at
least 20 seconds to ensure adequate absorption of saliva.
Swabs were then placed into collection tubes and refriger-
ated during transport to the laboratory within 24 hours,
where they were stored at −80°C pending laboratory
analysis.
At each in-home visit the field workers also collected
urine using a diaper insert. Filter papers (Whatman 903
grade, 1″ × 4″) were inserted into the inner panels of
the diapers prior to putting them on the children. After
urination, the inserts were removed from the diapers
and air dried. Diaper inserts were transported to the la-
boratory within 24 hours, and stored at −80°C pending
laboratory analysis.
During the last two weeks of follow up, the parents col-
lected daily saliva and urine samples using the methods
described above; these specimens were stored at 4°C
(home refrigerator) until they were picked up by the field
workers during their weekly visits. Among 864 possible
specimen collection opportunities (36 children × 24 pos-
sible collection days), only 16 saliva specimens and 18 urine
specimens were uncollected or were inadequate for testing.
Laboratory testing
As described in more detail in Stowell et al. (companion
paper), DNA was extracted from oral swabs through a
quick extract method and from filter paper via thermal
shock method [15]. In both cases, specimens were
evaluated for the presence of CMV DNA using real-
time PCR [16].
The limits of PCR detection were estimated to be
1,600 copies/mL for saliva and 16,000 copies/mL for
urine. These limits are considerably higher than our de-
tection limit for sterile specimens (e.g., blood) collected
in clinical settings, which is 70 copies/mL [17]. Two fac-
tors led to these higher limits of detection: 1) To avoid
false-positives, the PCR assay cutoff was raised five-fold
from one copy per reaction (70 copies/ml) to five copies
per reaction (350 copies/ ml) because saliva is not sterile
and urine was collected in an unsterile manner, and un-
sterile specimens are more susceptible to trace amounts
of contamination from the environment; 2) The methods
of specimen collection (i.e., swabs and filter paper) were
necessary to enable in-home collection by mothers, but
they resulted in reduced sample volume which raised
the limit of detection approximately five-fold for saliva
in swabs and 50-fold for urine in filter paper.
Statistical analysis
We used a Chi-square test to compare shedding preva-
lences, and linear regression to measure the association
between age and log10 viral loads. We used generalized
estimating equations that accounted for within-person
correlation to compare median viral loads in saliva and
urine, and to assess risk factors for shedding.
Results
Of the 36 children, 20 (56%) were boys and 16 (44%)
were girls; 20 (56%) were white, 12 (33%) were Asian-
American, and 4 (11%) were of other race/ethnicity. At
enrollment, 11 (31%) were less than 12 months of age,
12 (33%) were 12–23 months of age, and 13 (36%) were
24–47 months of age. Of the 32 mothers of these
children (four mothers had two children in the study),
29 (91%) were CMV-seropositive.
During approximately 12 weeks of longitudinal follow
up with the 36 children, CMV DNA was detected in
59% of saliva specimens (502/846) and 20% of urine
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specimens (167/844) (Figure 1). However, a direct com-
parison of shedding prevalences is inappropriate because
the limit of PCR detection for saliva was lower than for
urine. When using the higher limit (i.e., 16,000 copies/
mL), the shedding prevalence in saliva was 40% (335/846)
(i.e., 167 saliva specimens had viral loads between 1,600
and 16,000 copies/mL).
The prevalence of shedding in CMV-seropositive chil-
dren was highly correlated with initial shedding status.
Those who were shedding in saliva and/or urine at the
Figure 1 Comparison of saliva and urine viral loads per mL across all specimens collected in longitudinal follow up. Circles are only
plotted for children who were shedding; negative results (i.e., viral loads below the limit of detection) are not plotted. Blue circles represent saliva
results, and yellow circles represent urine results. Shedding prevalences and viral loads are not directly comparable because the two specimen
types had different PCR limits of detection, due to their different collection formats.
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screening visit had CMV DNA detected in 84% of follow-
up saliva specimens (455/543) and 28% of follow-up urine
specimens (151/539); those who were not shedding at
the screening visit had CMV DNA detected in 16% of
follow-up saliva specimens (47/303) and 5% of follow-up
urine specimens (16/305). Those who were shedding at
the screening visit were also more likely to have attended
day care (P = 0.03), but had similar ages and IgG antibody
titers as those who were not shedding at the screening
visit (data not shown). IgG avidity was not significantly
different for those who were initially shedding and not
shedding (P = 0.13); however, antibody avidity was high for
all eight of the non-shedders who had avidity data, sug-
gesting that their infections were not recent.
We found that younger children in our study had a higher
prevalence than older children of CMV shedding in saliva
and urine after adjusting for within-person correlation, but
the association was only statistically significant for urine
(P = 0.01, Table 1). Children who ever attended daycare had
a higher prevalence of shedding in saliva and urine, but the
association was not statistically significant (Table 1).
Among DNA-positive specimens, we found median
viral loads of 82,900 copies/mL in saliva and 34,730 cop-
ies/mL in urine (P = 0.01), while the viral loads for the
75th percentile were nearly 1.5 million copies/mL for
saliva compared to 86,800 copies/mL for urine. If the
saliva specimens had used the same limit of detection as
urine (i.e., 16,000 copies/mL), their median viral load
would have been 629,370 copies/mL rather than 82,900
copies/mL. Approximately 30% of saliva viral loads were
greater than one million copies/mL, with some even top-
ping 100 million copies/mL. Less than 2% of the urine
viral loads were above one million copies/mL (Figure 1).
At visits where children were shedding, log10 CMV viral
loads were correlated with age (Figure 2). The correlation
was especially strong for saliva: for example, children
12 months of age had average viral loads in saliva
approximately 300 times those of children 36 months of
age (P < 0.001). The correlation with urine was statisti-
cally significant (P = 0.003) but was not strong (regres-
sion coefficient = −0.012), nor did it explain much of the
variance around the regression line (r2 = 0.05) (Figure 2).
All children who were shedding at the screening visit
were still shedding on at least some of the days 10–12
weeks later, and the majority of these children were
shedding in saliva and/or urine at nearly every data col-
lection point (Figure 3). Among children who were not
shedding at the screening visit, most shed at only a few
visits during follow up (Figure 3). In general, children
who were shedding in urine were also shedding in saliva,
but children who were shedding CMV in saliva often
were not shedding in urine. Some of this discrepancy
may have been due to the less-sensitive PCR detection
limit for urine. Nevertheless, children who were shed-
ding in saliva were much more likely to also be shedding
in urine than were children not shedding in saliva
(unadjusted odds ratio = 7.7, p < 0.001). Similarly, chil-
dren shedding in any fluid were much more likely to be
shedding at the next visit compared to those who were
not shedding (Table 2).
Within individuals, CMV viral load varied somewhat
over time during the follow-up period (Figure 4). How-
ever, the heaviest shedders at enrollment tended to con-
tinue to shed CMV at high levels. Children who were
shedding in both body fluids tended to have higher viral
loads (Figures 3 and 4). No major changes in either the
group prevalences of shedding or the mean or median
viral loads were observed during 12 weeks of follow up
(Figure 5). Viral loads were also fairly stable at the indi-
vidual level from one visit to the next (Figure 6).
Discussion
Our main findings from this study were: 1) among
healthy, young, CMV-seropositive children, those who
Table 1 Risk factors for CMV shedding (yes vs. no) adjusting for within-person correlation
Saliva Urine
Variable Odds ratio (shedding) 95% CI P value Odds ratio (shedding) 95% CI P value
Sex
Girl 1 0.88 1 0.21
Boy 1.1 0.3–4.2 0.6 0.3–1.3
Age (months)
>24 1 0.12* 1 0.01
13–24 4.0 0.9–17.8 2.8 1.3–6.2
0–12 3.9 1.0–14.8 7.3 3.2–16.8
Daycare attendance
Never 1 0.13 1 0.15
Ever 2.4 0.8–7.8 1.8 0.8–3.8
*P for shedding prevalence being homogeneous across age categories.
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were shedding CMV in saliva or urine tended to con-
tinue shedding for at least three months, usually at
relatively stable levels; 2) a small subset of children
shed at extremely high levels, and are presumably a
more likely source of transmission to pregnant women;
3) the highest viral loads (>1×106 copies/mL) were
found in saliva; and 4) CMV shedding occurred at
higher viral loads among younger children.
Some of the findings in this study were similar to previ-
ous observations, but several of our findings were novel.
Children's ages (months)
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Figure 2 CMV viral loads per mL as a function of children’s ages in months. Panel A shows results for saliva viral loads, and panel B shows
results for urine viral loads. Circles are only plotted for children who were shedding; negative results (i.e., below the limit of detection) are not
plotted. Blue circles represent saliva results, and yellow circles represent urine results. The regression line in Panel A is log10 (CMV viral load) =6.9–0.095
(age in months), with r2 = 0.39 and P < 0.001; the regression line in Panel B is log10 (CMV viral load) =4.9–0.012 (age in months), with r
2 = 0.05 and P = 0.003.
Figure 3 CMV viral shedding among individual children by specimen type over the course of the study.
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Many studies have examined CMV shedding among
healthy children (reviewed in [18]), but few have collected
longitudinal data [19-22]. We could not identify any stud-
ies that assessed CMV shedding at weekly or daily inter-
vals as we did. In our study, we found that the presence of
shedding was highly correlated over time and viral loads
were relatively stable over days and weeks, even for as
long as three months. This suggests that young children
who are documented CMV shedders will probably con-
tinue shedding, and therefore may pose an ongoing risk to
pregnant women. Our findings further suggest that even
seropositive children who are initially not shedding have a
reasonable chance of occasionally shedding CMV over the
next few months, although usually at much lower viral
loads (Figure 4). Our data suggest that children may typic-
ally shed CMV for a longer duration than adults, but it is
difficult to make a valid comparison because longitudinal
studies in adults have only assessed blood rather than sal-
iva or urine [18]. If differences in viral loads or duration of
shedding exist, they could be caused by physiological dif-
ferences between children and adults (e.g., intensity of
viral replication, immune system control), by a higher
probability of recent infection among children, or by chil-
dren’s more frequent exposures to re-infection from other
Table 2 Correlation of CMV shedding from one visit to the next
Shedding status by specimen: Positive at current visit/positive
at previous visit (%)
Positive at current visit/negative
at previous visit (%)
Risk ratio 95% Confidence interval
Weekly visits Urine 37/76 (49) 33/293 (11) 4.3 2.9–6.4
Saliva 211/235 (90) 17/149 (11) 7.9 5.0–12.3
Either specimen 218/245 (90) 18/132 (14) 6.5 4.2–10.1
Daily visits Urine 47/91 (52) 44/354 (12) 4.2 3.0–5.9
Saliva 229/267 (86) 24/174 (14) 6.2 4.3–9.1
Either specimen 235/276 (85) 25/161 (16) 5.5 3.8–7.9
Figure 4 CMV viral load among individual children over the course of the study. Viral load was determined by taking the highest value of
the saliva or urine viral load. Saliva viral load was highest in 801 of the 858 patient visits that had available results.
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children. Differences in CMV viral loads have also been
found in rhesus macaques, where juveniles had signifi-
cantly higher viral loads than adults [23].
Another new finding was the extremely high viral
loads in the saliva of healthy young children. Although a
number of studies have measured CMV viral loads
among children with congenital CMV infection [16,24],
few studies have measured viral loads among healthy
children (i.e., not congenitally infected), the group most
relevant for transmission to pregnant women. In fact, we
were only able to identify two such studies [25,26], and
these were smaller than our study and reported only
mean viral loads rather than the entire distribution of
viral loads. Nearly half of the 502 CMV DNA-positive
saliva specimens in our study contained >100,000 cop-
ies/mL and more than one quarter had >1×106 copies/
mL (Figure 1). In contrast, CMV viral loads in adults
tend to be substantially lower (Stowell et al., companion
paper) [27]. Many of the highest viral load specimens
were obtained from a relatively small number of children
(Figure 3)—perhaps 6 or 7 of the 161 originally screened.
This may explain in part why CMV shedding is relatively
common [18] and yet incident infections are relatively
uncommon [14], i.e., the probability of transmission may
be low unless viral loads are high.
The higher prevalence of shedding in saliva compared
to urine was somewhat surprising. Most previous studies
have found higher shedding prevalences in urine, typic-
ally 2%–20% higher than in saliva [18]. However, our
large difference in shedding prevalence by specimen
(40% in saliva vs. 20% in urine using the same limit of
detection) cannot be compared to the results from those
previous studies; our study design selected for shedders,
including a preponderance of saliva shedders, and then
sampled from them repeatedly. Our cross-sectional
screening study, which is directly comparable to the
previously published studies, showed an approximately
3% higher shedding prevalence in saliva, though the
difference was not statistically significant (Stowell et al.,
companion paper). It is unclear why we did not find a
higher shedding prevalence in urine, compared with saliva,












































































Figure 5 CMV shedding prevalences and viral loads over time. Panel A: Group mean and median CMV viral loads in saliva by visit number.
Panel B: CMV shedding prevalences in saliva by visit number. Panel C: Group mean and median CMV viral loads in urine by visit number.
Panel D: CMV shedding prevalences in urine by visit number.
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might be that our study and previous studies had import-
ant differences in laboratory procedures—we collected
urine using filter paper and tested for CMV DNA using
PCR, whereas all previous studies [18] collected liquid
urine and tested for CMV using viral cultures.
On the other hand, the higher viral loads that we
found in saliva compared to viral loads in urine were not
necessarily unexpected. We identified two previous stud-
ies of healthy CMV seropositive children that compared
viral loads in saliva to urine [25,26]. In those studies,
mean viral loads were about five times higher in saliva.
It is unclear why some seropositive children shed
CMV while others did not. It is possible that a few of
the younger children may have only had maternal IgG
and no infection of their own. Four of the seropositive
children who were not shedding at recruitment were
younger than 12 months old. One of these children
began shedding CMV at high levels later on, suggesting
that at most three children could fall into the category
of not being infected. For those who truly were in-
fected, the occurrence of shedding may depend on the
level of immune control, the particular viral strain, the
time since initial infection, or less re-exposure to CMV
reinfections.
Our study highlights the potential importance of saliva
exposures for child-to-woman transmission of CMV. In
addition to saliva sometimes having very high viral loads,
women also report behaviors associated with potential
exposures to children’s saliva more frequently than be-
haviors associated with potential exposures to urine. Ac-
cording to a survey of more than 2000 women, kissing
on the lips, sharing utensils, sharing cups, and sharing
food are all common activities for women and children
[28]. Women may also be exposed to saliva while wip-
ing children’s faces. In contrast, most exposures to
urine occur while changing diapers, and most women
report that they clean their hands after most diaper
changes [28]. Importantly, many saliva exposures allow
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Figure 6 Histogram of changes in CMV viral load category from one visit to the next for saliva and urine. For example, a visit with a
viral load in the 105–106 copies/mL category that was followed by a visit with a viral load in that same category would be added to the
“zero” column of the histogram. On the other hand, if the visit was followed by a visit with a viral load in the 106–107 copies/mL category
or the 104–105 copies/mL category, it would be added to the “one” column of the histogram.
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for direct transfer to mucous membranes, whereas
most urine exposures require an intervening step in-
volving hands, thereby reducing the chance for CMV
to remain viable [29].
Another important conclusion from our study is that
younger children may pose greater transmission risk
than older children because of their tendency to shed
CMV at higher levels. This is especially important since
younger children also introduce more fluids into the en-
vironment (e.g., through drooling, mouthing toys, etc.)
than do older children.
Thus, the framing and presentation of CMV preven-
tion messages must take into account the potential risk
posed by exposure to young children’s saliva. In the past,
some messages have emphasized hand washing, primar-
ily as a way to reduce exposure to urine after diaper
changing [5,30,31]. Although hand washing should re-
main an important part of prevention messaging, saliva
exposures need to be addressed prominently. Interven-
tion studies have shown that messages that highlight
ways to reduce exposures to saliva are generally accept-
able to women [6,32].
Our study had several limitations. First, although we
had more than 800 patient-visits and nearly 1,700 speci-
mens tested, we followed a relatively small number of
children (N = 36). It is possible that the children we
followed differ in important ways from the general
population of healthy, CMV-seropositive children. This
might matter if, because of their age, race/ethnicity, or
socioeconomic status, the children in our study were
more or less likely than the general population of chil-
dren to be re-exposed to CMV infection. The second
limitation is that our study was not designed to assess
risk factors for seroconversion, only risk factors for
shedding. Although we could show that saliva can have
extremely high levels of CMV DNA, we did not measure
the extent to which such viral loads are associated with
transmission to another person. A third limitation is that
due to the conditions of specimen collection (e.g., in-home
collection, filter paper collection, longer-term storage for
the daily specimens) we did not routinely place the speci-
mens in viral cultures but used PCR to quantify CMV
DNA; thus, the presence of infectious virions was not
demonstrated in most cases. This approach would be
expected to overestimate the number of infectious par-
ticles in specimens. For a small number of specimens
we also performed viral cultures and often found evi-
dence for infectious virions but did not quantify them
(unpublished data). However, the study conditions were
chosen by design because they were the only way we could
repeatedly collect specimens at short time intervals. A
fourth limitation is that saliva and urine were collected
using different materials (swabs vs. filter paper), which
complicated between-fluid comparisons because urine
had a higher limit of detection (Figure 1). Nevertheless,
viral loads were substantially higher in saliva than in
urine with or without adjustment for the different
limits of detection.
Conclusions
In conclusion, healthy, young, CMV-seropositive children
can shed CMV for months at high, relatively stable levels.
These data suggest that behavioral prevention messages
need to address transmission via both saliva and urine,
but also need to be informed by the potentially higher
risks posed by saliva and by exposures to younger
children.
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